In vivo uptake of β-amyloid by non-plaque associated microglia

Area of Science:

• Neuroscience
• Immunology
• Alzheimer's Disease Research

Background:

• The function of microglia in Alzheimer's disease (AD) regarding amyloid-beta (Aβ) deposition and clearance is not fully understood.
• Prior research has concentrated on microglia associated with parenchymal plaques, neglecting interactions with non-plaque associated microglia.
• The direct role of microglia in mediating Aβ uptake after anti-amyloid treatment remains unknown.

Purpose of the Study:

• To investigate the role of non-plaque associated microglia in regulating cerebral Aβ levels in an Alzheimer's disease mouse model.
• To determine if microglia directly mediate Aβ uptake following treatment with an anti-amyloid compound.

Main Methods:

• TgCRND8 mice, which express mutations linked to familial Alzheimer's disease, were used to model amyloid pathology.
• Aβ-positive microglial processes were identified in the cortex and hippocampus using ionized calcium binding protein-1 (Iba1) staining.
• Mice were treated with 1-deoxy-1-fluoro-scyllo-inositol, and cognitive function, amyloid burden, and microglial responses were assessed.

Main Results:

• Aβ-positive microglial processes were found associated with microglia not adjacent to extracellular plaques.
• Treatment with 1-deoxy-1-fluoro-scyllo-inositol dose-dependently improved spatial memory and reduced amyloid pathology.
• The treatment increased intra-microglial Aβ levels in the hippocampus without promoting microglial proliferation or peripheral macrophage infiltration.

Conclusions:

• Non-plaque associated microglia play a previously unrecognized beneficial role in managing cerebral Aβ levels in a mouse model of AD.
• Microglia can directly mediate Aβ uptake following treatment with specific anti-amyloid agents.
• Targeting microglial Aβ uptake represents a potential therapeutic strategy for Alzheimer's disease.